Insider Transactions in Q3 2021 at Alector, Inc. (ALEC)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 23
2021
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
9,625
-0.42%
|
$240,625
$25.1 P/Share
|
|
Sep 22
2021
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
100,000
-2.08%
|
$2,500,000
$25.7 P/Share
|
|
Sep 21
2021
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
100,000
-2.0%
|
$2,600,000
$26.32 P/Share
|
|
Sep 20
2021
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
100,000
-1.92%
|
$2,600,000
$26.05 P/Share
|
|
Sep 10
2021
|
Kristine Yaffe |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$36,000
$18.1 P/Share
|
|
Aug 09
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
22,950
-4.47%
|
$619,650
$27.48 P/Share
|
|
Aug 09
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,950
+2.96%
|
$252,450
$11.82 P/Share
|
|
Aug 05
2021
|
Richard H Scheller |
SELL
Open market or private sale
|
Direct |
56,260
-96.99%
|
$1,519,020
$27.97 P/Share
|
|
Aug 05
2021
|
Richard H Scheller |
BUY
Exercise of conversion of derivative security
|
Direct |
56,260
+50.0%
|
$562,600
$10.14 P/Share
|
|
Jul 07
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
29,749
-3.88%
|
$1,130,462
$38.29 P/Share
|
|
Jul 07
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,749
+3.75%
|
$327,239
$11.82 P/Share
|
|
Jul 06
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-1.98%
|
$1,110,000
$37.71 P/Share
|
|
Jul 06
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+10.19%
|
$510,000
$17.15 P/Share
|
|
Jul 06
2021
|
Calvin Yu Vice President, Finance |
SELL
Open market or private sale
|
Direct |
3,334
-4.17%
|
$113,356
$34.65 P/Share
|
|
Jul 06
2021
|
Calvin Yu Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
3,334
+1.38%
|
$36,674
$11.82 P/Share
|
|
Jul 02
2021
|
Richard H Scheller |
SELL
Open market or private sale
|
Direct |
9,981
-100.0%
|
$309,411
$31.14 P/Share
|
|
Jul 02
2021
|
Robert King Chief Development Officer |
SELL
Open market or private sale
|
Direct |
60,000
-10.3%
|
$1,860,000
$31.14 P/Share
|
|
Jul 02
2021
|
Robert King Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+5.03%
|
$540,000
$9.15 P/Share
|
|
Jul 02
2021
|
Calvin Yu Vice President, Finance |
SELL
Open market or private sale
|
Direct |
110,840
-34.56%
|
$3,879,400
$35.58 P/Share
|
|
Jul 02
2021
|
Calvin Yu Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
60,840
+10.74%
|
$669,240
$11.82 P/Share
|
|
Jul 02
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-11.35%
|
$930,000
$31.14 P/Share
|
|
Jul 02
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,326
+6.15%
|
$294,542
$17.15 P/Share
|
|
Jul 01
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
26,726
-9.76%
|
$587,972
$22.23 P/Share
|